DAM
CLLS

Deltec Asset Management’s Cellectis CLLS Stock Holding History

Deltec Asset Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,000
Closed -$330K – 153
2016
Q1 		$330K Hold
12,000
– – 0.08% 106
2015
Q4 		$372K Buy
+12,000
New +$364K 0.09% 109

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
THSP
Taube Hodson Stonex Partners London, United Kingdom $488M AUM 4.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deltec Asset Management's CLLS Position: Q2 2016 in Review

Deltec Asset Management sold out of Cellectis (CLLS) in Q2 2016, closing a stake of 12,000 shares — an estimated $330K sold.

Deltec Asset Management first reported a position in CLLS in Q4 2015 and held it in 2 quarters. The position peaked at $372K in Q4 2015. 38 funds tracked by Wall St. Rank hold CLLS as of Q2 2016.

  • Deltec Asset Management reported no remaining Cellectis position as of Q2 2016 after selling out during the quarter.
  • Deltec Asset Management sold 12,000 Cellectis shares in Q2 2016, an estimated $330K.
  • Deltec Asset Management first reported a position in Cellectis in Q4 2015 and held it in 2 quarters.
  • Deltec Asset Management's Cellectis position peaked at $372K in Q4 2015.
  • 38 funds tracked by Wall St. Rank held Cellectis as of Q2 2016.

Based on Deltec Asset Management's 13F filing for Q2 2016, filed 26 Jul 2016.